Allergan plc
(NYSE : AGN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
0.55%149.152.8%$350.37m
ZTSZoetis, Inc. Class A
-0.34%84.651.9%$194.43m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
0.42%17.722.1%$189.65m
MYLMylan N.V.
1.49%29.273.2%$120.44m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
2.49%37.072.0%$11.13m
TXMDTherapeuticsMD, Inc.
2.64%3.7025.3%$10.36m
ABEOAbeona Therapeutics, Inc.
-2.33%7.147.9%$4.88m
TAROTaro Pharmaceutical Industries Ltd.
0.08%86.086.3%$4.66m
LFVNLifeVantage Corporation
2.60%13.813.3%$2.76m
PETXAratana Therapeutics, Inc.
1.01%6.038.7%$1.74m
KINKindred Biosciences, Inc.
0.44%11.360.3%$1.39m
JAGXJaguar Animal Health, Inc.
-3.73%0.289.8%$0.09m
CPHIChina Pharma Holdings, Inc.
-0.39%0.230.1%$0.05m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded on in 1984 and is headquartered in Dublin, Ireland.